35
Growth Score in past quarter
pts
Heat Score 35 in past quarter
-29 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
923131
Illumacell develops light technology for cancer treatment using Photodynamic Therapy.
- Tom Kerber: Founder & CTO
About the Company
Illumacell develops medical light technology used in cancer treatment through Photodynamic Therapy. The company focuses on engineering light devices capable of deeper tissue penetration than traditional PDT systems, enabling selective treatment of cancerous tissues. Its approach involves eliciting a phototoxic response in targeted cells, offering a
non-invasive treatment protocol. It concentrates on advancing the design and application of these light-based technologies for broader clinical use in oncology, supporting research and development in photomedical therapies.